Loading university
Raghu Kalluri — Dr. Raghu Kalluri's lab focuses on understanding exosomes, tiny particles that cells release into the bloodstream, and their roles in cancer, particularly pancreatic cancer. They investigate how these exosomes contribute to cancer progression and explore innovative ways to use engineered exosomes as potential therapies. The lab aims to uncover the mysteries of exosome biology and harness their properties for improving cancer diagnosis and treatment.
Ronald Anthony Depinho — Dr. Ronald Anthony Depinho's lab at the University of Texas MD Anderson Cancer Center focuses on understanding how specific gene deletions in cancer cells can create unique vulnerabilities. By identifying these weak spots, the lab aims to develop precision cancer therapies that target only cancer cells while sparing normal ones. They utilize advanced techniques such as CRISPR to explore these genetic interactions and aim to improve treatment outcomes for cancer patients.
Bogdan A Czerniak — Dr. Bogdan A Czerniak's lab focuses on understanding bladder cancer, a common and deadly disease. The research aims to identify how bladder cancer develops and evolves, particularly looking at the cellular changes that contribute to its severity and resistance to treatment. By characterizing the molecular mechanisms involved, the lab aims to develop new therapies to improve early detection and treatment outcomes for bladder cancer patients.
Xi Chen — Dr. Xi Chen's lab focuses on understanding how mutant KRAS, a common gene mutation in several cancers, influences tumor growth and response to treatment. They are particularly interested in how cancer cells adapt to therapies and develop resistance, with a specific focus on a molecular process called proteostasis. By targeting these mechanisms, the lab aims to improve the effectiveness of existing treatments for lung, pancreatic, and colorectal cancers, potentially leading to better outcomes for patients.
John A. Tainer — Dr. John A. Tainer's lab at the University of Texas MD Anderson focuses on understanding how DNA repair mechanisms work in cancer cells. They study the response of cancer cells to DNA damage and how different DNA repair pathways are activated during this process. Their work combines innovative technologies and data analysis to uncover the complex interactions between DNA repair, mitochondrial function, and cancer biology, ultimately aiming to improve cancer therapies and patient outcomes.
Chun Li — Dr. Chun Li's lab focuses on developing new therapies for hepatocellular carcinoma (HCC), a type of liver cancer that is becoming increasingly common. The lab is exploring the use of polymeric micelles that can deliver dual drug therapies effectively to target cancer stem cells and other tumor cells. This innovative approach aims to improve treatment outcomes and ultimately provide better survival rates for HCC patients.
Junjie Chen — Dr. Junjie Chen's lab at the University of Texas MD Anderson Cancer Center focuses on understanding how cells repair DNA damage and the role of specific enzymes in cancer treatment. They explore the mechanisms behind DNA topoisomerases, which are crucial for managing DNA structure during crucial cellular processes. The lab aims to develop improved cancer therapies by targeting DNA repair pathways and enhancing the effectiveness of current treatment strategies.
Tao Wang — Dr. Tao Wang's lab focuses on using machine learning to analyze complex biological data, specifically to predict interactions between antigens and antibodies. Their research aims to enhance our understanding of the immune system, contributing to the development of new diagnostic tools and therapeutic antibodies for autoimmune diseases. By combining advanced sequencing technologies and deep learning models, the lab addresses critical challenges in immunology and bioinformatics.
Susan Bullman — Dr. Susan Bullman's lab at the University of Texas MD Anderson Cancer Center focuses on understanding the interactions between specific bacteria, particularly Fusobacterium nucleatum, and colorectal cancer. The team investigates how these bacteria alter the tumor environment and influence cancer progression and patient outcomes. Their research aims to uncover novel therapeutic targets that could improve cancer treatment and prevention.